Low-Dose Naltrexone (LDN) Explained: A Doctor's Guide
New Blog Post Description
Written by Dr. Kara Wada
New Blog Post Description
In this Virtual Sjogren's Summit roundtable, doctors discuss why the 15-min model fails chronic illness patients (Sjogren's, Dysautonomia, MCAS) & how to advocate for better care.
Dr. Kara Wada and Janet Steins share candid patient experiences in Sjogren's clinical trials (Dazodalibep, Nipocalimab), discussing challenges, benefits, and hopes for the future.
Understand the key differences between MCAS (Mast Cell Activation Syndrome) and traditional allergies, why diagnosis is tricky, and how to advocate for answers.
© 2025 Dr Kara Wada. All Rights Reserved.